Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Alirocumab Plus Cemiplimab in Immunorefractory NSCLC: A Single Arm Phase 2 Study.
Journal: Research square
Published: July 03, 2026
CRE26-055: A Novel Case of Immune Checkpoint Inhibitor-Mediated DAT-Negative Autoimmune Hemolytic Anemia.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: April 29, 2026
CRE26-055: A Novel Case of Immune Checkpoint Inhibitor-Mediated DAT-Negative Autoimmune Hemolytic Anemia.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: March 30, 2026
Erratum: Prevalence and Clinical Characteristics of Germline Epidermal Growth Factor Receptor Mutations in the Southeastern United States.
Journal: JCO precision oncology
Published: March 02, 2026
Broadening clinical trial inclusivity of patients with lung cancer and brain metastases utilizing the Graded Prognostic Assessment (GPA): A call to action.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: February 02, 2026
Prevalence and Clinical Characteristics of Germline Epidermal Growth Factor Receptor Mutations in the Southeastern Unites States.
Journal: JCO precision oncology
Published: January 21, 2026
A multi-institutional perspective on tarlatamab administration and management of CRS/ICANS.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: November 17, 2025
Multi-Institution Analysis of Tarlatamab for the Treatment of EGFR-Mutant Transformed Small Cell Lung Cancer.
Journal: JCO precision oncology
Published: October 30, 2025
Quantitative HER2 tissue and plasma profiling predicts the activity of trastuzumab deruxtecan for breast cancer.
Journal: NPJ precision oncology
Published: September 06, 2025
Given TKIs With High CNS Penetrance, Systemic Therapy Should Be Administered Before Radiation Therapy for CNS Metastases.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: July 20, 2025
Management outcomes for biopsy-proven radiation necrosis in patients with brain metastases in the era of immune-checkpoint blockade.
Journal: Journal of neuro-oncology
Published: May 06, 2025
Neoadjuvant, Perioperative, and Adjuvant Immunotherapy in Early-Stage Surgically Resectable Non-Small Cell Lung Cancer: Updates and Future Perspectives.
Journal: Cancers
Published: April 28, 2025
Last Updated: 09/26/2026